2-METHYL-AP-237.HCL

Related products

• 

  Rated 0 out of 5

  EMYLCAMATE

  €280.00 – €7,000.00

  Emylcamate (marketed as Striatran by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate, which was the market leader at the time. It is no longer prescribed. A study of the drug’s effects in mice was done in 1959. It concluded that at 50 mg/kg emylcamate gave a 63% decrease in motor activity compared with meprobamate’s 32% decrease, a doubling in effective potency. The therapeutic index in mice was also established: ED50 (mg/kg):123 Emylcamate also has a faster intra-parenteral onset then meprobamate, 3 minutes compared with 35

  This product is intended for research and forensic applications

  Select options

  Quick View
• 

  Rated 0 out of 5

  Buy molly in Germany

  Molly is not new, exactly. MDMA, or 3,4-methylenedioxy-N-methylamphetamine, was patented by Merck pharmaceuticals in 1914 and did not make much news until the 1970s, when psychotherapists began giving it to patients to get them to open up. It arrived at New York nightclubs in the late 1980s, and by the early ’90s it became the preferred drug at raves at Limelight and Shelter, where a weekly party called NASA later served as a backdrop in Larry Clark’s movie “Kids.”

  Read more

  Quick View
• 

  Rated 0 out of 5

  25B-NBOH HCL

  €50.00 – €16,000.00

  Iupac name: 2-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol CAS number: 1335331-46-8 Molecular Weight:365.06 g/mol Chemical Formula: C17H20BrNO3

  25B-NBOH (NBOH-2C-B) is a derivative of the phenethylamine derived hallucinogen 2C-B which has been sold as a designer drug It acts as a potent serotonin receptor agonist with similar affinity to the better-known compound 25B-NBOMe at 5-HT2A and 5-HT2C receptors with pKis values of 8.3 and 9.4, respectively

  Select options

  Quick View
• 

  Rated 0 out of 5

  Buy codeine in Germany

  Consider the possibility of misuse before prescribing

  The possibility of misuse should be considered if warning signs are present, such as patients requesting an analgesic without a clear indication or insistently requesting codeine, higher doses or a stronger opioid, asking for early repeats or reporting losing medicines or prescriptions.

  Read more

  Quick View
• 

  Rated 0 out of 5

  O-DSMT .HCL

  €280.00 – €8,000.00

  Emylcamate (marketed as Striatran by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate, which was the market leader at the time. It is no longer prescribed. A study of the drug’s effects in mice was done in 1959. It concluded that at 50 mg/kg emylcamate gave a 63% decrease in motor activity compared with meprobamate’s 32% decrease, a doubling in effective potency. The therapeutic index in mice was also established: ED50 (mg/kg):123 Emylcamate also has a faster intra-parenteral onset then meprobamate, 3 minutes compared with 35

  This product is intended for research and forensic applications

  Select options

  Quick View